Skip to main content

Table 2 Tpl-2/Cot expression in PBMC

From: Expression of the Tpl2/Cot oncogene in human T-cell neoplasias

Patient no.

Tpl2-Norma

Fold increase (R)b

CV(%)-Rc

Ctr (n = 3)

0.04 ± 0.019

1.00 ± 0.119

45.3

1

0.02 ± 0.000

0.59 ± 0.009

1.6

2

0.13 ± 0.005

3.88 ± 0.149

3.8

3

0.13 ± 0.005

4.04 ± 0.143

3.5

4

0.02 ± 0.003

0.66 ± 0.092

13.9

5

0.04 ± 0.005

1.22 ± 0.092

11.8

6

0.06 ± 0.003

1.70 ± 0.085

5.0

7

0.06 ± 0.002

1.81 ± 0.076

4.2

8

0.17 ± 0.008

5.21 ± 0.251

4.8

9

0.01 ± 0.000

0.32 ± 0.007

2.2

10

0.16 ± 0.006

5.04 ± 0.194

3.8

11

0.04 ± 0.001

1.09 ± 0.037

3.4

12

0.04 ± 0.004

1.22 ± 0.108

8.9

  1. a. Tpl2/Cot normalized to GAPDH by equation (3) in the text ± SD.
  2. b. Tpl2/Cot-Norm (sample) ratio to Tpl2/Cot-Norm (control) by equation (2) in the text ± SD. Samples in which Tpl2/Cot is overexpressed are shown in bold.
  3. c. % Coefficient variance of (R).